I'm the co-founder and CTO at BillionToOne. I'm happy to answer any questions here. I've also posted a slightly more technical explanation of how the test works and why it can scale here: https://twitter.com/dtsao/status/1247642005510873088?s=21 Edit: Since our site seems to be overwhelmed at the moment, here's a recap: We’ve been working hard at BillionToOne on a new COVID-19 test that scales testing to everyone in…
Thanks for the link to the scientific manuscript. Can you speak more about the machine learning aspect? Best of luck on getting FDA approval.
The core of our machine learning is Ax=b :grins:
More seriously, the main reason why traditional sanger sequencing can't be used for COVID-19 testing is because it would be unclear whether a lack of signal is truly due to lack of virus, or if it is just because the assay failed (happens all the time!)
What we've done is introduce a reference sequencing signal that is biochemically very similar to viral RNA, but produces a distinct vector of electrical signals that is different from the signals emitted by viral RNA. Since we know what both the reference and viral signals look like, we can perform linear regression analysis to fit the linear combination of viral and reference signals that best match our data.